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Abstract 
BACKGROUND: We present to the attention of the medical, dermatological and oncosurgical community data 
that serves to indicate the indispensability of optimisation of the algorithm and recommendations for diagnosis and 
surgical treatment of cutaneous melanoma. These recommendations could be referred to different subgroups of 
patients in different clinical stages as well as to patients with different initial characterisation (histological 
morphology) of the primary tumours. One step surgery is not a myth, even more, it could prove to be one of the 
best solutions for some patient collectives with advanced stages of melanoma.  
CASE REPORT: We present a case of a 74 - year old patient with a congenital medium sized melanocytic nevus, 
located directly above the lateral part of the elbow joint. In one month and a half, an achromatic nodular formation 
evolves with a diameter of 2.7 x 2.3 cm, prominent over the skin level, painful by palpation and spontaneously 
bleeding. By the anamnestic, clinical and dermoscopic findings the patient was diagnosed with nodular melanoma 
associated with a congenital medium sized melanocytic nevus. A primary excision with a field of safety 0.5 cm in 
all directions was performed. After confirmation of the primary diagnosis (tumour thickness 8 mm with no 
ultrasonographic detection of enlarged lymph nodes), seven days later are - excision was performed with an 
additional field of surgical safety of 1.5 cm in all directions.  
CONCLUSIONS: In this case remains unclear the following question: For what reason a preoperative high - 
frequent ultrasonography (HFUS) is not recommended to be used as it will allow only one surgical excision with 
the elimination of a tumour with a safety field of 2cm in all directions? The enigma about the obstacles preventing 
such a rational optimisation of the current diagnostic and therapeutic algorithm in patients with melanomas 
remains unresolved. One step surgery for cutaneous melanoma is widely used in many countries although it 
continues to be considered as a matter of dispute for some experts. Once again, by a clinical case and the 
following analysis, we would like to focus the attention of the dermatosurgical community on this crucial and highly 
significant problem. Innovations are very often resulting from the simplicity of logic, which unfortunately is not 
always accepted appropriately. 
 
 
 
 
Introduction 
 
Congenital melanocytic nevi (CMN) are 
benign proliferations of cutaneous melanocytic cells 
with incidence rate around 1% of the newborn infants 
[1]. They are composed of melanocytes which are 
grouped in focal nests in the epidermis, dermis or 
other tissues [2]. The definition “congenital” is 
expanded to melanocytic nevi that have occurred 6 
months to 2 years after birth, according to different 
authors who explain this late occurrence with the 
insufficient melanogenesis or the extremely small size 
of the nevus postpartum [3]. Clinical classification of 
CMN is based on their size as following: small nevi 
(greatest diameter less than 1.5 cm); medium nevi 
(greatest diameter between 1.5 - 19.9cm) and giant 
nevi (diameter 20 cm or more) [4]. The most important 
concern related to the CMN is their malignancy 
potential [5]. There are many investigations that serve 
to evaluate the risk of malignant transformation, and 
at the current stage of knowledge, it is proven that the 
larger size of the lesion is associated with a 
significantly higher risk of malignant melanoma 
development [6]. The estimated lifetime risk for 
evolution in melanoma is a matter of controversies, 
but conforming to most of the reported medical data it 
is approximately 5%, depending on the size of the 
primary lesion (1 - 5% for small CMN, to 5 - 10% for 
giant GMN) [7].  
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There are several main problematic points in 
the management of patients with congenital 
melanocytic nevi: 1) The lack of organized and well -
functioning centers for dermabrasio threatening of 
children in their first weeks to months after birth 
(concerning mainly giant congenital nevi) [8]; 2) The 
lack of well - trained dermatopathologists, who can 
quickly and accurately distinguish pseudomelanomas 
in infants from true melanomas (pseudomelanomas 
are dysplastic nevi, which in most cases are 
congenital small melanocytic nevi that are clinical, 
dermoscopically and histologically difficult for 
differentiating from real melanomas) [9][10]; 3) The 
lack of determination to more aggressive approach 
when it refers to medium sized melanocytic nevi, 
which are showing tendency of enhanced malignancy 
risk associated with increased age [11].  
Last but not least, it should be taken into 
account the reluctance of some dermatologists to 
perform a preventive surgical resection of medium-
sized congenital nevi, due to their insufficient 
competency level (national observations).  
To establish the widespread so-called 
confocal laser microscopy, it is appropriate the 
following important facts be presented: 1,) Diagnosis 
melanoma is based on a clinical examination in 60% 
of the cases and up to 25% it is based on 
dermoscopic findings. In only 15% of the cases, 
confocal laser microscopy can give some clarity for 
the genesis of the lesions and whether they have to 
be surgically eliminated [13][14]. 2) Confocal 
microscopy has its limitations in certain areas of the 
human body [15][16][17][18].  
Additionally, it has been found that the 
multifactorial genesis of melanomas, particularly in 
patients with dysplastic nevi syndrome shows various 
genetic mutations within a single patient, but also in 
every single lesion [19][20]. In simple terms, different 
nevi whether dysplastic or not, show diverse tendency 
and speed of nevus – to - melanoma evolving within 
the life of each patient. This means that two 
congenital or dysplastic nevi which seem to have 
completely identical clinical, dermoscopic, confocal - 
microscopic and even histological appearance, show 
entirely different malignisation tendency within an 
equal period in the same patient. It is interesting to be 
noted that the mutation analysis of several nevi in one 
patient shows significant differences [21][22][23]. This 
leads us to the conclusion that the personalisation of 
the medicine, in general, is inevitable even though it is 
still hard to achieve it by now. This particular 
reasoning underlay the logical statement that 
algorithms and high technologies could provide some 
advantages in the treatment of skin tumours, but they 
could by no means be equivalent or even a percentile 
equivalent of human logic. Melanoma guidelines 
suffer from lack of case – by - case personalisation 
and this leads to an inability of optimising the ultimate 
results. 
Case report 
 
A 74 – year - old female patient presented to 
the department of dermatologic surgery because of a 
nodular lesion with signs of malignancy, evolved 
within the borders of middle-sized congenital nevus. 
The lesion is located in the lateral brachial region of 
the right arm and has occurred one month and a half 
ago. The patient noticed rapidly increase in size and 
regular spontaneous bleeding. Local pruritus, pain 
and paresthesia were reported as additional 
subjective complaints.  
 
Figure 1: Clinical manifestation of nodular melanoma associated 
with congenital medium sized melanocytic nevus with Breslow 
thickness 8 mm, located in the lateral brachial region of the right 
arm of a 74 - year old patient 
 
Clinical examination observed brown 
pigmented macula with a diameter of 6.3 x 4.1cm, 
irregular borders and uneven distribution of colour. On 
approximately half of its size, an elevated nodule with 
diameter 2.7 x 2.3 cm, asymmetrical shape, dark red 
colour and irregular borders with central bleeding 
erosion is situated (Figure 1).  
 
Figure 2: Preoperative surgical skin marking with 0.5cm filed for 
safety in all directions 
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Figure 3: Elliptical surgical excision of the lesion under local 
anaesthesia 
 
No enlarged lymphatic nodes were identified 
by palpation. Conducted paraclinical examinations 
revealed elevated ESR – 52 mm/h (< 39 mm/h); WBC 
– 12.01 /l (3.5 - 10.5 /l); Neu – 8.990 l (1.900 - 
7.900l); GGT – 43 U/l (6.00 – 40 U/l); CRP – 5.70 
mg/l (< 5 mg/l). Chest radiography detected poorly 
expressed emphysematous and fibrous changes.  
 
Figure 4: Elliptical surgical excision of the lesion under local 
anesthesia 
 
The right paracardial and basal regions are 
showing linear non homogenous infiltrative changes 
probably due to small pleural effusion or adhesions. 
Normal cardiac silhouette was found.  
 
Figure 5: Wound closure with simple interrupted sutures 
 
Ultrasound examination did not detect any 
axillar, cervical or inguinal enlarged lymphatic nodes. 
The liver was no focal changes, sharp borders and 
homogenous structure. The lesion was removed by 
surgical excision under local anaesthesia, with 0.5 cm 
field of safety margins in all directions (Figure 2 - 5). 
 
Figure 6: Preoperative surgical skin marking of the re-excision with 
1.5 cm field for safety in all directions 
 
Histological examination of the cutaneous 
lesion revealed nodular malignant melanoma with 
tumour thickness 8mm (Breslow), Clark IV, with no 
signs of spontaneous regression, high mitotic activity, 
epidermal erosion, insignificant lymphocytic stromal 
reaction and clear resection margins.  
 
Figure 7: Wide elliptical surgical re-excision under local anaesthesia 
 
The patient was diagnosed in stage IIC and 
underwent reoperation with 1.5 cm field of safety 
(Figure 6 - 9). Afterwards was referred for registration 
in oncologic dispensary for regular monitoring.  
 
Figure 8: Wide elliptical surgical re-excision under local anaesthesia 
 
 
Discussion 
 
In the era of so-called personalised medicine, 
the current solutions for diagnosis and treatment of 
various diseases often are and should be challenged. 
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There are numerous factors that motivate the nation - 
following of certain guidelines but taking individual 
decisions for the therapeutic approach of a patient 
instead. Malignant melanoma should be considered 
as one of the most illustrative examples of such a non 
- standard model.  
 
Figure 9: Wound closure with simple interrupted sutures 
 
Critical reviews of the standard surgical 
treatment should not surprise the so-called experts 
because of four main facts and circumstances, as 
follows:  
1)  In the controversy with the great medical 
progress, we observe that even though pathogenesis 
of melanoma is multifactorial, the therapy is often 
(considered 2 years later) identical, regardless of the 
newly introduced target therapies. 
2)  It is unclear why melanomas over 8mm or 
16mm do not evolve locoregional or distant 
metastases compared to significantly thinner 
melanomas, which show high metastatic tendency 
and extremely aggressive potential [24][25]. 
3)  Rapidly changing therapeutic strategies for 
treatment of melanoma indicate a serious deficiency 
of orientation and a kind of helplessness among the 
medical community towards this never-ending 
problem. 
4)  Мedical centres have different access 
possibilities which are reflecting in diverse approaches 
to patients in general. Why OMICS analyses are 
available for certain collectives, and not for others? 
Isn’t this some high - tech personalised medicine 
which is available for a limited number and types of 
patients? 
All these facts lead our minds to the logical 
question concerning not the difficulty of the 
pathogenesis or the target therapy, but the 
significantly more simplified surgical treatment: Isn’t 
there any possibility for alleviation of the surgical 
treatment and reduction in the number of therapeutic 
interventions as well as the chances of incorrect 
assessment of the preoperative status? It is a simple 
question whether these factors can be somehow 
limited? And we believe that the answer is - definitely 
YES! 
By the presented case, we would like to 
express our critical view regarding the lack of any 
individual approach in the recommendations of 
melanoma treatment in Europe, the US and worldwide 
at least for some collectives of patients. In the case of 
our patient two medium - sized surgical interventions 
were performed with a favourable outcome despite 
the initial 8 mm tumour thickness. In cases of 
melanoma, over 4 mm and no locoregional 
metastases a sentinel lymph node biopsy and 
lymphаdenectomy are not recommended. Re - 
excisions, however, are. An open question remains - 
why in this initially clear clinical and dermoscopic 
case, guidelines do not recommend preoperative 
HFUS for detecting of the tumour thickness? Then, 
depending on the ultrasonographically measured 
thickness, only one single surgical excision could be 
performed?! In less thick melanomas this approach 
would lead to primary excision of the lesion with or 
without a sentinel lymph node biopsy at once, in a 
single surgical session. The surgical field of safety 
would be 1 cm or 2 cm in all directions, depending on 
whether the ultimately established thickness of the 
tumor is under or more than 2 cm [26]. This approach 
would be limited in cases of achromatic melanomas 
so they should be excluded from the category of 
tumors appropriated for this strategy. A possibility for 
their inclusion in the one - step melanoma surgery 
would be the use of confocal microscopy and/or 
cytological analysis in combination with 
immunohistochemical methods [27][28]. 
Although this concept would be considered as 
“frivolous” by many experts, the number of reduced 
surgical interventions and the optimization of the 
approach, in general, would lead to 1) Reduction of 
healthcare costs, 2) Limited possibilities of different 
mistakes by the therapists and patients (occurring 
between the two surgical interventions) and as an 
ultimate and most important outcome - 3) Long-term 
survival of the affected patient collectives would be 
expected. 
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